Stonebridge Capital Advisors’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-251
Closed -$32.3K 887
2023
Q3
$32.3K Sell
251
-50
-17% -$6.64K ﹤0.01% 418
2023
Q2
$40K Sell
301
-320
-52% -$42.2K ﹤0.01% 402
2023
Q1
$80.4K Buy
621
+320
+106% +$41.8K 0.01% 307
2022
Q4
$40.9K Hold
301
﹤0.01% 380
2022
Q3
$36K Sell
301
-50
-14% -$6.44K ﹤0.01% 383
2022
Q2
$45K Sell
351
-33
-9% -$4.33K 0.01% 363
2022
Q1
$53K Buy
384
+146
+61% +$19.3K 0.01% 385
2021
Q4
$34K Sell
238
-42
-15% -$5.58K ﹤0.01% 431
2021
Q3
$36K Sell
280
-214
-43% -$28.3K ﹤0.01% 391
2021
Q2
$60K Buy
494
+247
+100% +$30.3K ﹤0.01% 434
2021
Q1
$29K Buy
+247
New +$28.5K ﹤0.01% 439
2020
Q3
Sell
-192
Closed -$19K 732
2020
Q2
$19K Buy
192
+87
+83% +$8.59K ﹤0.01% 411
2020
Q1
$9K Buy
+105
New +$10.2K ﹤0.01% 502

Other funds holding XLV

Stonebridge Capital Advisors's XLV Position: Q4 2023 in Review

Stonebridge Capital Advisors sold out of State Street Health Care Select Sector SPDR ETF (XLV) in Q4 2023, closing a stake of 251 shares — an estimated $32.3K sold.

Stonebridge Capital Advisors first reported a position in XLV in Q1 2020 and held it in 13 quarters. The position peaked at $80.4K in Q1 2023. 1,641 funds tracked by Wall St. Rank hold XLV as of Q4 2023.

  • Stonebridge Capital Advisors reported no remaining State Street Health Care Select Sector SPDR ETF position as of Q4 2023 after selling out during the quarter.
  • Stonebridge Capital Advisors sold 251 State Street Health Care Select Sector SPDR ETF shares in Q4 2023, an estimated $32.3K.
  • Stonebridge Capital Advisors first reported a position in State Street Health Care Select Sector SPDR ETF in Q1 2020 and held it in 13 quarters.
  • Stonebridge Capital Advisors's State Street Health Care Select Sector SPDR ETF position peaked at $80.4K in Q1 2023.
  • 1,641 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q4 2023.

Based on Stonebridge Capital Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.